...
legn-img

Legend Biotech Corp, Common Stock

LEGN

NSQ

$34.08

+$0.06

(0.18%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$6.23B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.63M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.11
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$32.5 L
$70.13 H
$34.08

About Legend Biotech Corp, Common Stock

Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery, development, manufacturing, and commercialization of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multiple myeloma (MM). The company also has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. It has collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of ciltacabtagene autoleucel. The company was founded in 2014 and is based in Somerset, New Jersey. Legend Biotech Corporation operates as a subsidiary of Genscript Biotech Corporation. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameLEGNSectorS&P500
1-Week Return-2.96%-2.12%-3%
1-Month Return-15.1%-3.42%-0.73%
3-Month Return-29.78%-11.13%2.87%
6-Month Return-16.47%-5.74%7.17%
1-Year Return-43.21%3.97%25.31%
3-Year Return-27.46%1.05%28.38%
5-Year Return-7.89%34.37%81.89%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue57.26M75.68M89.79M117.00M285.14M[{"date":"2019-12-31","value":20.08,"profit":true},{"date":"2020-12-31","value":26.54,"profit":true},{"date":"2021-12-31","value":31.49,"profit":true},{"date":"2022-12-31","value":41.03,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue-232.16M313.35M65.36M144.21M[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":74.09,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":20.86,"profit":true},{"date":"2023-12-31","value":46.02,"profit":true}]
Gross Profit57.26M(156.48M)(223.55M)51.64M140.93M[{"date":"2019-12-31","value":40.63,"profit":true},{"date":"2020-12-31","value":-111.04,"profit":false},{"date":"2021-12-31","value":-158.63,"profit":false},{"date":"2022-12-31","value":36.64,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin100.00%(206.78%)(248.97%)44.14%49.42%[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-206.78,"profit":false},{"date":"2021-12-31","value":-248.97,"profit":false},{"date":"2022-12-31","value":44.14,"profit":true},{"date":"2023-12-31","value":49.42,"profit":true}]
Operating Expenses192.63M304.88M462.83M509.70M140.93M[{"date":"2019-12-31","value":37.79,"profit":true},{"date":"2020-12-31","value":59.82,"profit":true},{"date":"2021-12-31","value":90.8,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":27.65,"profit":true}]
Operating Income(130.87M)(313.35M)(393.02M)(455.83M)(439.49M)[{"date":"2019-12-31","value":-13087100000,"profit":false},{"date":"2020-12-31","value":-31334600000,"profit":false},{"date":"2021-12-31","value":-39302500000,"profit":false},{"date":"2022-12-31","value":-45582800000,"profit":false},{"date":"2023-12-31","value":-43948500000,"profit":false}]
Total Non-Operating Income/Expense4.86M(82.62M)(15.07M)(692.00K)(59.39M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-1700.27,"profit":false},{"date":"2021-12-31","value":-310.17,"profit":false},{"date":"2022-12-31","value":-14.24,"profit":false},{"date":"2023-12-31","value":-1222.35,"profit":false}]
Pre-Tax Income(130.37M)(307.62M)(386.21M)(445.72M)(520.12M)[{"date":"2019-12-31","value":-13037000000,"profit":false},{"date":"2020-12-31","value":-30762200000,"profit":false},{"date":"2021-12-31","value":-38620800000,"profit":false},{"date":"2022-12-31","value":-44572400000,"profit":false},{"date":"2023-12-31","value":-52011800000,"profit":false}]
Income Taxes2.60M(4.14M)1.00K625.00K(1.86M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-159.3,"profit":false},{"date":"2021-12-31","value":0.04,"profit":true},{"date":"2022-12-31","value":24.02,"profit":true},{"date":"2023-12-31","value":-71.64,"profit":false}]
Income After Taxes(132.97M)(303.48M)(386.21M)(446.35M)(518.25M)[{"date":"2019-12-31","value":-13297200000,"profit":false},{"date":"2020-12-31","value":-30347700000,"profit":false},{"date":"2021-12-31","value":-38620900000,"profit":false},{"date":"2022-12-31","value":-44634900000,"profit":false},{"date":"2023-12-31","value":-51825400000,"profit":false}]
Income From Continuous Operations(132.97M)(303.48M)(386.21M)(446.35M)(509.31M)[{"date":"2019-12-31","value":-13297200000,"profit":false},{"date":"2020-12-31","value":-30347700000,"profit":false},{"date":"2021-12-31","value":-38620900000,"profit":false},{"date":"2022-12-31","value":-44634900000,"profit":false},{"date":"2023-12-31","value":-50931200000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(132.97M)(303.48M)(386.21M)(446.35M)(518.25M)[{"date":"2019-12-31","value":-13297200000,"profit":false},{"date":"2020-12-31","value":-30347700000,"profit":false},{"date":"2021-12-31","value":-38620900000,"profit":false},{"date":"2022-12-31","value":-44634900000,"profit":false},{"date":"2023-12-31","value":-51825400000,"profit":false}]
EPS (Diluted)-(2.49)(1.35)(1.58)(2.96)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-249,"profit":false},{"date":"2021-12-31","value":-135,"profit":false},{"date":"2022-12-31","value":-158,"profit":false},{"date":"2023-12-31","value":-296,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

LEGN
Cash Ratio 4.48
Current Ratio 4.98
Quick Ratio 4.90

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

LEGN
ROA (LTM) -12.28%
ROE (LTM) -28.35%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

LEGN
Debt Ratio Lower is generally better. Negative is bad. 0.36
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.64

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

LEGN
Trailing PE NM
Forward PE 1000.00
P/S (TTM) 12.00
P/B 5.59
Price/FCF NM
EV/R 10.33
EV/Ebitda NM

FAQs

What is Legend Biotech Corp share price today?

Legend Biotech Corp (LEGN) share price today is $34.08

Can Indians buy Legend Biotech Corp shares?

Yes, Indians can buy shares of Legend Biotech Corp (LEGN) on Vested. To buy Legend Biotech Corp from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in LEGN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Legend Biotech Corp be purchased?

Yes, you can purchase fractional shares of Legend Biotech Corp (LEGN) via the Vested app. You can start investing in Legend Biotech Corp (LEGN) with a minimum investment of $1.

How to invest in Legend Biotech Corp shares from India?

You can invest in shares of Legend Biotech Corp (LEGN) via Vested in three simple steps:

  • Click on Sign Up or Invest in LEGN stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Legend Biotech Corp shares
What is Legend Biotech Corp 52-week high and low stock price?

The 52-week high price of Legend Biotech Corp (LEGN) is $70.13. The 52-week low price of Legend Biotech Corp (LEGN) is $32.5.

What is Legend Biotech Corp price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Legend Biotech Corp (LEGN) is

What is Legend Biotech Corp price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Legend Biotech Corp (LEGN) is 5.59

What is Legend Biotech Corp dividend yield?

The dividend yield of Legend Biotech Corp (LEGN) is 0.00%

What is the Market Cap of Legend Biotech Corp?

The market capitalization of Legend Biotech Corp (LEGN) is $6.23B

What is Legend Biotech Corp’s stock symbol?

The stock symbol (or ticker) of Legend Biotech Corp is LEGN

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top